Fraunhofer-Gesellschaft

News

Deutscher Zukunftspreis / 14.9.2022

Fraunhofer ISE team nominated for the German Future Prize 2022

1.8.2022

Three of the five Fraunhofer executive vice presidents start new in their posts

23.6.2022

EIT Culture & Creativity - a game changing organisation for a prosperous Europe

15.6.2022

Fraunhofer UK and Fraunhofer CAP celebrated tenth anniversary at the Royal Society

 

THE QUANTUM BREAKTHROUGH

"FUTURAS IN RES" conference: The Quantum Breakthrough | September 28–29, 2022 | Hilton Berlin

 

Trade fair for the plastics and rubber industry

Fraunhofer at the trade fair K

Düsseldorf, October 19 − 26, 2022

 

Fraunhofer lead markets

Our strategic customer segments provide industry customers with access to Fraunhofer’s industry-oriented services.

 

Fraunhofer magazine
2/2022

Protection and security

A new era, new challenges, new solutions

Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.

 

Headquarters

Hansastraße 27c
80686 München
Germany
Phone +49 89 1205-0
Fax +49 89 1205-7513 

Latest News

1.9.2022

Proxidrugs in the fight against pathogenic proteins

Cells have an efficient waste disposal system. Proxidrugs utilize this system as part of new treatments for cancer, infections and Alzheimer’s disease. Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP are working with partners to develop this new drug class.
Read more

1.9.2022

Algorithms for manufacturing mRNA-based pharmaceuticals

Back in 2019, BioNTech was far from a household name. Nowadays, however, the pharmaceutical company from Mainz is world-famous for developing and producing Comirnaty©, a COVID-19 vaccine. The company’s original aim was to develop personalized mRNA-based treatments to fight cancer – a goal that it continues to pursue to this day. Since 2016, a research team at the Fraunhofer Institute for Industrial Mathematics ITWM has collaborated with BioNTech to optimize the planning, management and documentation of their production processes. This work culminated in the development of two software platforms, one for vaccines and one for cancer treatments, which help organize and optimize the production processes at BioNTech today. These systems are in use and are continuously adapted and improved as situations and requirements change.
Read more

1.9.2022

Green adhesives made from whey

In collaboration with TU Dresden, Fraunhofer researchers have developed a process for obtaining valuable, high-purity ethyl acetate from whey. This can be used, for example, to produce environmentally friendly adhesives, thereby replacing conventional ethyl acetate extracted from fossil-based raw materials. It also eliminates the need for costly disposal of the molasses produced during whey processing.
Read more

1.9.2022

Out with the silver, in with the copper: A new boost for solar cell production

The rising price and low availability of raw materials, especially silver, are leading to higher costs in producing photovoltaic modules. Fraunhofer researchers have developed an electroplating process that involves substituting silver, an expensive precious metal, with copper, which is more readily available. They have also succeeded in replacing the polymers that are usually left over after electroplating processes, and are expensive to dispose of, by instead using easily recyclable aluminum for masking. In order to bring the technology to the market more quickly, the spin-off PV2+ was launched.
Read more